Oculogica, Inc.
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
A Highly Portable Device for Assessment of Mild Traumatic Brain Injury in Deployed and Far-Forward Settings
Role: lead
EyeBOX Concussion Study and Registry
Role: lead
Oculogica Portable EyeBOX Study
Role: lead
Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure
Role: lead
Oculomotor Assessment of Traumatic Brain Injury (TBI)
Role: collaborator
Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication
Role: lead
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
Role: lead
All 7 trials loaded